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In the field of forensic science, it is important to have reliable, accurate, 
and nondestructive testing methods for evidence collection and testing. Current 
methods, such as gas chromatography-mass spectrometry (GC-MS) and high-
performance liquid chromatography (HPLC), are destructive to evidence and 
require lengthy sample preparation. Because of its nondestructive nature, 
specificity, and portability, Raman spectroscopy has been increasingly improving 
forensic science. The goal of this work is to expand on the growing pool of 
knowledge of forensics related Raman applications.  
 One problem that has plagued forensic scientists for years is how to 
accurately identify the time since death, or post-mortem interval. Scientists have 
been able to estimate time since death based on physical evidence and 
environmental factors, but it has notoriously proven difficult to quantify this 
information. It has been difficult for scientists to find a biomarker of post-mortem 
interval. Herein, we present a Raman study of amino acids to determine possible 
biomarkers. We also present the first use of spatially offset Raman spectroscopy 
(SORS) to identify potential biomarkers of post-mortem interval through a whole 
bovine eye.  
 Another area where Raman spectroscopy has previously shown to be 
useful previously is in the study of bone composition. Although the chemical 
composition of bone is well understood, how bone composition changes through 
the bone healing process is not as well understood. Here we show the potential 
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of SORS to be used as a tool to estimate the age of bone fractures by changes in 
chemical composition over time. It is our hope that in the future this method could 
be developed further and used to age bone fractures of child abuse victims in 
vivo.   
 The further development of the results of this work could lead to faster, 
portable, specific, and nondestructive determination of forensically relevant 
information from in vivo samples. Successful development of these techniques 
could revolutionize the field of forensic evidence analysis by improving chemical 
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Raman spectroscopy is a nondestructive, portable technique that utilizes 
the properties of molecules’ interaction with light and the scattering of light by the 
target molecule to obtain chemical information about a sample. Recently, Raman 
spectroscopy has become widespread in the areas of forensic science and 
diagnostics due to its nondestructive and specific nature. Our motivation for using 
Raman spectroscopy is that the technique gives way to improving the current 
status of forensic analysis of biological materials. The nondestructive, portable 
nature of the technique is desirable for use on human subjects because it can be 
applied non-invasively.  
1.2 Raman Spectroscopy 
    
Raman Spectroscopy is a vibrational spectroscopy that involves 
interaction between a molecule and an electromagnetic field, which leads to 
vibrational and rotational excitation resulting in the scattering of a photon by a 
molecule. This effect is known as the Raman Effect, discovered in 1928. The 
phenomenon of light scattering occurs when there is a collision between a 
molecule and a photon, resulting in energy being transferred between the two. As 
shown in Figure 1, after excitation, light can be scattered elastically, resulting in 
no change in energy (Rayleigh scattering) or inelastically, resulting in a change in 
energy (Raman scattering).1 Raman scattering can be classified in one of two 






Figure 1. Light Scattering. Interaction of incident light causes a molecule 










Figure 2. Jablonski Diagram. Reproduced from Lam et. al depicting the energy changes 




electron in a vibrational level higher than the ground state is excited to a meta-
stable transition state, then relaxes down to the ground state. This results in 
scattered light of a shorter wavelength and higher energy than the incident light. 
Stokes scattering results in scattered light of a longer wavelength and lower 
energy than the incident light. As seen in Figure 2a,2 Stokes scattering occurs 
when an electron starts in the ground vibrational state, is excited to a metastable 
virtual state, and relaxes down to a vibrational level higher than the initial energy 
level. Because electrons are more likely to be found in the ground state due to 
the ground state being lower in energy and thus more energetically favorable, 
Stokes scattering is more common. In all the experiments described hereafter, 
Stokes scattering was utilized.  
 To be Raman active, a molecule must have a change in polarizability 
when it vibrates. When monochromatic light is incident on a molecule, the 
molecule experiences an induced dipole moment given by the equation 1.1, 
where a is the polarizability, µ is the induced dipole, and E is the electric field.3  
    µ	induced = a * Efield                                     Equation. 1.1 
Raman spectroscopy is a useful technique for several reasons. Raman 
spectroscopy is  chemically specific, meaning it is possible to obtain a unique 
molecular signature for each chemical component of a sample. It is also a rapid, 
portable, nondestructive technique that requires little to no sample preparation, 
which makes this technique appealing to the forensics field.  
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1.2.1 Spatially Offset Raman Spectroscopy (SORS) 
 When using conventional Raman spectroscopy, light from a sample is 
scattered back along the same trajectory as the incident laser light, so the 
scattering signal measured is from the surface of the sample. Spatially offset 
Raman Spectroscopy (SORS), allows for deeper levels of a sample to be probed 
nondestructively than would be possible with conventional Raman. SORS, 
developed by Matousek et. al,4 employs the same concepts as conventional 
Raman, except after the sample is illuminated, spectra are collected at a point 
offset from the incident light. As the collection point is moved farther from the 
incident point, the information obtained arises from deeper layers, shown in 
Figure 3. This is because, due to the photon migration effect, photons migrate 
laterally through the subsurface layers before scattering back out.4 As light 
propagates through the sample, it becomes more evenly dispersed through the 
subsurface layers, scatters back out, and is collected.  
 Two main geometries, shown in Figure 4, for collecting signal exist. Signal 
can be collected in a backscattering (180 degree) geometry, or transmission 
geometry. Backscattering geometry is more common and involves irradiation of a 
sample and focusing the collected light back onto the detector. Transmission 
geometry involves displacing the collection and illumination areas to an extreme 
extent and is useful in measuring through the bulk of a sample to find an analyte 
in an unknown location.  In our experiments, we will use backscattering geometry 








Figure 3. SORS Theory. Incident light enters sample, some light interacts with surface 
and scatters back out. The rest travels through the sample. Photons migrate laterally and 








Figure 4. Collection Geometries. There are two types of collection 
geometries including a) backscattering and b) transmission. There are three 
types of backscattering geometry including point collection, conventional 




There are three ways light can be collected in a backscattering geometry, 
seen in Figure 4. Firstly, point collection involves collecting signal at different 
zones laterally offset from the point of illumination. This method relies on the 
user’s ability to properly manage optics to achieve the desired offset. 
Conventional SORS requires illuminating the sample at a point, and signal is 
collected from a point offset from the illumination, typically by a fiber optic probe. 
Conventional SORS is limited in what offsets can be achieved because of the 
diameter of the fiber optic probe, as the fiber optic probe diameter cannot be 
change.  Fiber optic probes increase sensitivity, however, conventional SORS 
suffers because of spectral distortions caused by different signals being collected 
at the same time on the CCD camera.5 The final method to collect SORS signal 
is called inverse SORS. In this method of signal collection, either a fiber optic 
probe or a special optical lens called an axicon lens, shown in Figure 5, can be 
used to create the annular illumination (illumination in a ring).5,6 An axicon 
focuses light into beams that form a ring and spatial offset and is simple to 
manipulate, while also dispersing power over a wider area so that intensity 
restrictions are yielded.7 Depth of light propagation can be manipulated easily by 
moving the axicon so that the ring formed is of the desired offset, where the 
radius of the ring is the spatial offset and thus the depth propagated. Added 
benefits of inverse SORS include higher sensitivity, deeper probing depths than 
conventional SORS, and power is spread over a larger area so larger power can 
be delivered to tissues in vivo without surpassing maximum permissible 
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exposure. In the experiments to be described here, we will be collecting SORS 
spectra using the inverse SORS collection method using an axicon lens (Figure 
5).  
1.2.2 Surface Enhanced Raman Spectroscopy (SERS) 
The intensity of Raman signal is dependent on the cross-sectional area of 
the molecule, σRS, and the photon flux, I0.1 This can be described by equation 
1.2.  
𝐼$% = σ$%	𝐼(                                   Equation 1.2 
The cross-sectional area of molecules are usually on the order of 10-29 cm2, 
which can cause Raman intensity to suffer.8 In the case of weak signal, it is 
possible to increase signal by using a technique known as surface enhanced 
Raman spectroscopy (SERS).  
 SERS utilizes a property of plasmonic metals called the localized surface 
plasmon resonance (LSPR), shown in Figure 6.9 Surface conduction electrons of 
the metal oscillate, creating an enhanced electric field at the junction of the metal 
nanoparticles, termed a “hot spot”. The LSPR is dependent on size, shape, 
composition, and dielectric environment.10 The resulting enhanced electric field 
along with other factors such as the reduced cross-sectional areas associated 
with SERS, leads to an increased Raman signal, thus improving signal to noise 








Figure 5.Axicon Lens. Depiction of how an axicon lens directs the beam into a circle. 
The beam width remains the same around the whole circumference and spatial offset is 







Figure 6. Localized Surface Plasmon Resonance (LSPR). Conduction 
electrons around on the surface of a metal oscillate and create an increased 




The capability of nanoparticles to enhance signal can be described by the 
enhancement factor. This factor is a description of the magnitude of 
enhancement in SERS signal. Enhancement factor can measure on the order of 
108.12 Analytical enhancement factor is described by equation 1.3, where I is 
intensity, and c is concentration of analyte adsorbed to the nanoparticle surface 
in the sample.   




                                     Equation 1.3 
 
In these experiments, SERS was combined with SORS, termed SESORS, to 
determine whether combining SERS with SORS increased the signal in the 
samples being measured. SERS was also used to look at biomolecules to decide 
where peaks were that we should expect. 
1.3 Instrumentation and Methods  
1.3.1 Micro Raman Setup  
As shown in Figure 7, a 785 nm diode laser is directed off multiple 
reflecting mirrors through two irises. Laser light is then directed up into the Ti-U 
inverted microscope (Nikon) equipped with a 20X magnification objective to the 
sample. Scattered light from the sample is then sent through a longpass filter, 
which filters out Rayleigh light. After going through the longpass filter, Raman 
light enters the spectrometer (Princeton Instruments Isoplane SCT 320) and then 
is translated into signal on a charge-coupled device (CCD) detector (Princeton 







Figure 7. Micro-Raman System. Schematic of homebuilt micro-Raman system 







1.3.2 Macro Raman Setup  
Shown in Figure 8, a 785 nm diode laser is directed off two mirrors, 
through two irises, and through a focusing lens, which focuses the laser spot. 
Light is then directed off a dichroic mirror, which reflects light at a 90° angle onto 
the sample. Then a lower energy light (Stokes) is scattered back out of the 
sample at 180 degrees, passes through the other side of the dichroic mirror. The 
light then goes through a set of collimating lenses, where it is focused onto the 
spectrometer slit. A holographic longpass filter is then used to filter out Rayleigh 
light at 785 nm, and the Stokes light enters the spectrometer (Princeton 
Instruments Acton LS-785), where it is then converted to an image by a CCD 
detector (Princeton Instruments Pixis 400). 
1.3.3 Nanoparticle Synthesis and Characterization  
Gold nanoparticles (AuNPs) were synthesized by following a modified 
Frens synthesis protocol.13 A 10-2 % gold colloid solution was made with 18 MΩ 
cm ultra-pure water and tetrachloroauric acid (HAuCl4). Next, a 1% citrate 
solution was made with trisodium citrate (Na3C6H5O7). In an Erlenmeyer flask, 45 
mL of gold solution was brought to a boil and 300 μL of citrate solution were 
added to the boiling solution. The solution should go through color changes until 
it reaches a dark red/pink color after approximately 5 minutes. At this point, the 
reaction is complete. Absorption spectra were taken with a UV-Vis Spectrometer 
(Cary 5000, Agilent) to characterize the nanoparticles. The absorption peak is 






Figure 8. Macro Raman System. Schematic of home-built Raman system in 180 





usually ranges from 525-540 nm for gold. A representative gold absorption 
spectrum is shown in Figure 9. 
Silver nanoparticles (AgNPs) were synthesized by following the Leopold 
Lendl hydroxylamine method. 14 First, aqua regia was used to clean glassware. A 
1 M hydroxylamine hydrochloride solution was made. Then a 1M NaOH solution 
was made. Next, a 10mM AgNO3 solution was made. Next, 89.995 mL of H2O, 
300 μL of the 1M NaOH, and 150 μL of the hydroxylamine hydrochloride was 
added to a flask. The solution was stirred on a stir plate at 300 RPM. Lastly, 10 
mL of AgNO3 was added all at once and stirred for 5 minutes. Absorption spectra 
were collected, and the LSPR was typically around 409 nm. To further test 
nanoparticles, 1 mL of nanoparticle solution was centrifuged. For AuNPs, this 
was at 4200 RPM for 15 minutes and for AgNPs was at 6000 RPM for 7 minutes. 
Then supernatant was removed. Next, 200 μL of 100μm benzenethiol (BT) was 
added to the nanoparticles, which were then diluted to 1 mL with 800μL of 18 MΩ 
cm ultra-pure water. The solution incubated for 45 minutes, at which point a 
SERS spectrum was collected, shown in Figure 10. A confocal Raman set-up 
(20X objective), previously shown in Figure 7 was used. Each SERS spectrum of 
BT was acquired for 1 s at 5 mW of power at the sample with 785 nm excitation 
wavelength (λexcitation) to show that nanoparticles were functionalized and gave 
appropriate signal. This was completed each time a new batch of nanoparticles 






Figure 9. Absorption Spectrum. UV-Vis absorption of gold nanoparticles, 









Figure 10. SERS of Benzenethiol. SERS spectrum of benzenethiol on gold 
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This chapter details the collection of normal Raman and SERS signatures of 
potential biomarkers that had been determined by previous studies in the 
literature to be of particular interest as biomarkers in determining post-mortem 
interval. 3,4-12 Uric acid, lactic acid, hypoxanthine, phenylalanine, tyrosine, 
tryptophan, L-proline, L-alanine, and L-glycine were studied by various methods 




2.1 Abstract  
 
The presentation of scientific evidence in criminal cases is of paramount 
importance, oftentimes being the deciding factor in if a person is declared 
innocent or guilty. For this reason, forensic testing methods need to be as 
accurate and specific as possible. One of the most important pieces of a case is 
the estimated time of death, otherwise known as the post-mortem interval (PMI). 
Historically, physical changes such as rigor mortis, have been used to determine 
the PMI. Studies of temperature cooling, gastric contents, putrefaction, and 
entomology have also been used. Although these methods provide a general 
estimate, it would be desirable to determine a more specific window for time of 
death. Raman spectroscopy and surface enhanced Raman spectroscopy could 
be utilized to nondestructively and quickly determine time since death by 
estimating a more specific time frame of PMI. The first step in using this 
technique to estimate PMI is to determine which biomarkers should be targeted. 
We chose to investigate biomarkers previously mentioned in literature using 
normal Raman and SERS with both gold and silver nanoparticles to determine 
what molecules we should target.   
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2.2 Introduction  
Forensic scientists face numerous challenges in their day to day work. 
One of the most important yet difficult pieces of information to determine in a 
death investigation is the time elapsed since death, also known as the post- 
mortem interval, or PMI.  
Death is scientifically defined as when respiratory, brain, and circulatory 
function cease irreversibly. 1 Several changes occur post-mortem, including 
supravitality, livor mortis, and rigor mortis. Supravitality refers to when an 
organism's tissues can still metabolize, but the organism is dead. Metabolism in 
the early stages after death occurs by anaerobic glycolysis and the creatine 
kinase reaction. Information learned from early post-mortem stages could be 
used to estimate PMI. 1 Livor mortis, rigor mortis, and algor mortis have been 
signals for estimating PMI since the 1800s. 2 Livor mortis is the first stage after 
death, and it is characterized by pooling of blood at the bottom of a corpse. In the 
beginning of livor mortis, blood is light pink colored, but it can turn dark colored 
due to the lack of oxygen as time goes on. 1 Rigor mortis develops starting at 3-4 
hours after death, starts in the face, and proceeds to larger muscles, including 
skeletal and smooth muscles, and lasts up to 76 hours. After death, muscles 
become flaccid, but during rigor mortis, the creatine kinase reaction produces 
ATP by anaerobic glycolysis. As this happens, actin and myosin in muscle still 
form bridges, and this allows the muscle to still contract after death. Muscles can 
stay rigid, in their contracted state, up to 76 hours. The end of rigor mortis is 
signaled by the increase in concentration of ammonia, indicating protein 
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degradation. 1 The time and extent of rigor mortis is highly variable and can be 
influenced by many factors such as temperature, environmental factors, and the 
amount of glycogen in the muscles at the time of death. Algor mortis refers to the 
cooling of the body after death and occurs in three stages: the initial phase, the 
intermediate stage, and the terminal phase. During the initial phase, which 
occurs right after death, the body temperature remains constant. When the body 
temperature decreases rapidly, the intermediate phase of algor mortis occurs. 
The terminal phase is when the body cools down to the temperature of its 
surroundings. 1  
Complications in estimating PMI are introduced when PMI estimation is 
based solely on observation because of variability in the environment and 
circumstances surrounding the death. There is a need to determine PMI more 
quantitatively to increase accuracy. Previous studies have identified possible 
biomarkers of post-mortem interval including hypoxanthine, uric acid, formate, 
lactate, amino acids, and acetate, among others. 3,4-12 Hypoxanthine is a product 
of purine degradation, which has been identified in multiple studies as a potential 
biomarker for PMI. 3, 5-6, 9 Since proteins degrade with time, it is proposed that 
increase in amino acid concentration might also be indicative of post-mortem 
interval. Appanna, Donaldson and Lamont aimed to investigate pH changes and 
concentration changes of six metabolites, including lactic acid, hypoxanthine, 
ammonia, NADH, and formic acid post-mortem from blood samples using 
assays. 5 They determined that hypoxanthine, ammonia, and NADH could be the 
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best indicators of PMI in blood. Another study by Kage et al. determined 
concentrations of formate and acetate simultaneously in post-mortem blood by 
GC-MS. 7 
It is necessary to determine what tissue is most suitable for PMI 
estimation. For this reason, Zelentsova et al. used HPLC and NMR to study 
changes in 61 different metabolites in post-mortem rabbit blood serum and ocular 
fluids in order to determine which fluid was more suited for PMI estimation. 3 
Serum and ocular fluids were collected before death and at intervals of 1, 2, 4, 6, 
10, 14, 23, and 31 hours post-mortem and metabolites were quantified. It was 
determined that hypoxanthine, choline, and glycerol showed the most significant 
and linear increase in concentration with time and metabolic changes happen 
much slower in aqueous humor (AH) and vitreous humor (VH) samples than in 
blood. Ocular fluids also showed less data scattering, indicating that AH and VH 
samples are better suited for PMI analysis than blood samples.  
Investigations into biomarkers of PMI and indicators of disease in aqueous 
and vitreous humors have been attempted, but these studies have used invasive, 
destructive, less specific, and/or time consuming methods like GC, LC-MS, UV-
Vis, ion-selective electrodes, and photometry. 9, 11 Thierauf et al. used 
photometric methods and electrochemistry and showed that sodium, potassium, 
calcium, chloride, urea, creatinine, glucose, and lactate could be observed in 
vitreous humor. 11 Patrick and Logan have observed amino acids in vitreous by 
an amino acid analyzer after much sample preparation; they determined that 
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amino acid concentrations were directly related to post-mortem interval, and 
taurine, glycine, alanine, phenylalanine, and histidine contributed the most to 
vitreous total amino acid content. 13 Ansari et al. used silver nanoparticle (AgNP) 
based sensors with colorimetric detection to study cysteine as a potential marker 
of time since death, and they determined a limit of detection of 0.007 μg/mL for 
cysteine in vitreous, as well as a linear correlation with increasing PMI. 4 Girela et 
al. studied amino acid concentrations in vitreous humor and cerebrospinal fluid 
(CSF) using HPLC. 14 They determined taurine, glutamate, and aspartate, which 
are all amino acids, increased in concentration with statistical significance in 
vitreous humor as PMI increased. Snytnikova et al. looked at the metabolomics 
of the human cornea and aqueous humor using NMR and HPLC with high 
resolution ESI-MS detection. 15 They found that concentrations of purines and 
organic acids in the cornea are higher than in the aqueous humor, indicating the 
cornea could be a better target than the aqueous humor. Based on these studies, 
amino acids, urea, creatinine, glucose, and lactate in vitreous or compounds in 
the cornea could be possible targets for the use of Raman spectroscopy to 
determine PMI. 4, 11, 13-15 
We aimed to determine which biomarkers suggested should be targeted in 
future studies. We utilized various methods of normal Raman and SERS 
nanoparticles to study which biomarker would be an ideal target for studying time 
of death in eye tissue. Here we studied uric acid, lactic acid, phenylalanine, 




Raman spectra of solid uric acid, lactic acid, and hypoxanthine were each 
collected at 5 mW of power for 60 seconds with a 785 nm excitation wavelength. 
Next, 100 mM solutions were made of each and normal Raman spectra were 
collected with the same parameters. Samples were then diluted to their desired 
concentrations which were based on their solubility limits. For each separate 
sample, 1 mL of AuNPs were centrifuged at 4200 RPM for 15 minutes. Then, 100 
μL of each sample solution were added to the AuNPs and incubated for 45 
minutes. Hydroxylamine silver nanoparticles were also used to detect these 
molecules following the same procedure, apart from changing time and speed 
centrifuged to 7 minutes at 6000 RPM. Raman spectra of these solutions were 
collected at 785 nm excitation at 5mW of power and 60 s acquisition time.  
Proteins are of abundance in the human body, especially in the eye lens, 
so we were also interested in studying the optimal way to detect amino acids 
using SERS. Amino acids tyrosine, tryptophan, phenylalanine, L-alanine, L-
proline, and glycine were studied using SERS on both the micro and macro 
systems. SERS gold nanoparticle (AuNP) samples were prepared by spinning 
down 1mL of AuNPs in a centrifuge at 4200 RPM for 15 minutes. Hydroxylamine 
silver particles (AgNPs) were prepared by spinning 1mL in the centrifuge for 7 
minutes at 6000 RPM. Then, 200 μL of the specified sample were added to the 
respective particles. SERS spectra collected on the micro- system were collected 
at 785 nm excitation wavelength, 5 mW of power, 20X objective, and 60 s 
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acquisition time.  SERS spectra collected on the macro system were collected at 
785 nm excitation wavelength, 90 mW of power, and 60 s acquisition time. 
Normal Raman spectra collected were from the solid sample and the 100mM 
sample, both being collected at 90mW of power and 785 nm excitation 
wavelength on the macro-system and 5 mW of power and 785 nm excitation on 
the micro-system. SERS spectra were collected from solutions ranging in 
concentration from 100 μM to 100 mM. pH of each sample was also adjusted 
when necessary by adding 1 μL of 3M HCl before spectra collection.  
2.4 Results and Discussion  
 
It was determined that gold nanoparticles should be used when analyzing 
lactic acid, uric acid, and hypoxanthine because they resulted in increased 
signal. Limits of detection (LOD) and optimum pH were also studied. Eventually, 
it was decided to not move forward with these studies on lactic acid, uric acid, 
and hypoxanthine, however, as we were concurrently studying biological 
materials and were not seeing these molecules within the materials we were 
interested in. Although the information gained from these analytes was not useful 
for our purposes and thus not shown here, we were able to show that lactic acid, 
uric acid, and hypoxanthine can be detected using SERS if need be.  
As seen in Figure 11, it was shown that phenylalanine, tryptophan, and 
tyrosine SERS spectra were easily measured on the micro-system with AuNPs. 
Their spectra are shown here. The other analytes did not have as good of SERS 
spectra on the micro-system and are not shown here. It was determined that the 
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three analytes most suited to measuring on the micro-system with AuNPs were 
tryptophan, tyrosine, and phenylalanine. It can be seen in Figure 11 that each of 
these three analytes showed distinct Raman spectra with multiple peaks only 
appearing in the molecule of interest. This indicated that if we were to measure 
SERS spectra of these three analytes, it would be desirable to use gold 
nanoparticles at 785 nm excitation.  
 The amino acids most suited to SERS measurement on the macro-system 
with hydroxylamine AgNPs were phenylalanine, proline, and alanine. As seen in 
Figure 12, Raman signal of these three analytes showed prominent peaks that 
were not attributed to the hydroxylamine nanoparticles. The other analytes had 
resulted in spectra that were mostly contributed to by the nanoparticles, so it was 
determined that this was not the optimum method for tryptophan or tyrosine.  
2.5 Conclusions and Future Work 
 
 It was concluded that SERS spectra of amino acids of interest in biological 
applications could be collected on both the micro- and macro-Raman systems in 
the Sharma lab. The best SERS signal was obtained from phenylalanine on both 
systems as well as with both types of nanoparticles. Phenylalanine SERS 
spectra could be measured in various ways, it was determined that phenylalanine 
is most likely the best target analyte for our studies into post-mortem interval, as 


















c) Tyrosine and AuNPs 
 
 
Figure 11. SERS of Amino Acids with gold nanoparticles. The amino acids 
a) phenylalanine, b) tryptophan, and c) tyrosine gave the best Raman signal 
out of the amino acids tested with gold on the micro-system. Spectra were 
collected on the micro system at 785 nm excitation, 5mW of power, and 60 
















c) Proline and AgNPS 
 
 
Figure 12. SERS of Amino Acids with hydroxylamine silver nanoparticles. 
The amino acids phenylalanine, alanine, and proline gave the most distinct 
SERS spectra on the macro- Raman setup  with AgNPs at 785 nm excitation, 







 For our purposes, we were solely interested in whether or not we could 
measure the signal of these amino acids and what kind of particles we would 
need to use to detect them, so more investigation in regards to the specific 
parameters that should be used to detect these amino acids remains. Future 
work would be to optimize conditions used to measure SERS spectra of amino 
acids. We would need to test different incubation times, different pH values, as 
well as different power directed onto the samples. We could also try to use 
different shapes and sizes of nanoparticles to enhance detection. Micro-flowers, 
nanorods, or nanostars could further increase the signal obtained from amino 
acids and may make the amino acids that were hard to detect more detectable. 
Once we obtain optimum signal, it would be necessary to determine the limits of 
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This chapter details the use of SORS to measure through different areas of 
bovine eyes for the potential to determine post-mortem interval. SORS spectra at 
3 different spatial offsets (0,2, and 5mm) were collected through the front, side, 
and back of bovine eyes. Results showed that measuring through the front of the 
eye is promising for detecting biomarkers, and measuring through the side and 
back of the eye resulted in collagen signatures.  This is the first that we know of 
that SORS has been used to measure through the whole eye.  
 
A version of this chapter is being prepared for submission to The Journal of 





3.1 Abstract  
Composition of the eye has been studied for years because of the 
prevalence of eye disease. It has also recently been suggested that the eye 
could contain biomarkers that are indicative of post-mortem interval (the time 
passed since death). Studying the composition of the eye could lead to improved 
medical and forensic methods. Previous studies have utilized methods such as 
GC-MS, LC-MS, UV-Vis, and photometry. However, these methods are often 
destructive and invasive. It is desirable to use a nondestructive, fast, specific, 
and portable technique to observe the chemical composition of the eye. This is 
the first study to date to our knowledge that has used spatially offset Raman 
Spectroscopy (SORS) to study the eye. SORS was used to probe through the 
front, side, and back of whole bovine eyes at different depths ex vivo. Raman 
signatures arising from the crystalline proteins of the lens can be observed 
through the front of the eye, and collagen can be observed through the side and 
back of the eye. It was concluded that SORS can detect biomolecules non-
destructively below the surface of the eye and could be useful to diagnose 





Understanding the composition of the eye could be useful in 
understanding diseases that affect millions of people worldwide. According to the 
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National Eye Institute, by 2030, 3.7 million Americans will have age-related 
macular degeneration, 4.3 million will have glaucoma, 11.3 million will have 
diabetic retinopathy, and 38.7 million will have cataract disease. 1 These 
numbers will increase as time goes on, making it imperative to diagnose these 
diseases early on. The eye is not only of interest in the study of disease, but it 
also serves as an accessible point for biomarker testing. It has been suggested 
that biomarkers in various parts of the eye such as amino acids could be useful 
to the forensics field for post-mortem interval determination. 2-3  
            Numerous methods including GC-MS, LC-MS, UV-Vis, and photometry 
have been used to measure biomarkers in the eye, but these methods are 
commonly invasive, destructive, less specific, and/or tedious. 4-5 Raman 
spectroscopy is a nondestructive, noninvasive method that has previously been 
used to study eye components. In 1975, Yu et al. 6 used Raman spectroscopy to 
study the water soluble proteins of bovine lens and determined that they 
contained mostly antiparallel pleated sheet structure in main chains and 
sulfhydryl groups are localized in g-crystallin proteins. In 1982, Yu et al. showed 
that it was possible take Raman spectra of a live rabbit lens in situ. 7 Bot et al. 
used Raman spectroscopy to study intact fresh and paraformaldehyde fixed 
rabbit lens slices. 8 In the same study, they compared the Raman spectrum of a 
human lens with the Raman spectrum of a slice of the same human lens. It was 
concluded that paraformaldehyde had little effect on the lens spectrum and that 
the Raman spectra of whole lenses and lens slices were comparable; they also 
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concluded that lens slices could be used to lessen fluorescence and improve 
accuracy of position at which Raman spectra are recorded. In 1991, Sokolov et 
al. used surface enhanced Raman spectroscopy (SERS) to look at eye lens 
extracts, and they concluded that SERS is effective in probing biomolecules in 
human and chipmunk lenses. 9 They determined that adenosine-containing 
molecules were abundant, and tyrosine and tryptophan signals were intense in 
cataract samples from humans. Vrensen et al. studied protein profiles in the 
superficial cortex, deep cortex, and nucleus of aged human lenses using micro-
Raman spectroscopy, and found that there was no significant difference in 
protein profiles in the three different regions. 10 They also were able to give peak 
assignments to the Raman spectra of the lenses. Glutamate has also been 
identified in the eye by Raman spectroscopy. 11 A study by Prieto-Bonete et al. 
showed that morphological and histological changes in the eye lens could be 
useful for estimating post-mortem interval. 12 Although previous research has 
provided useful information about the chemical composition of the eye, no 
method that we are aware of has been used to probe multiple layers of an eye 
without destroying the eye, which is why we aimed to apply spatially offset 
Raman spectroscopy (SORS) to measure through multiple layers of the eye.  
Spatially offset Raman spectroscopy is a variant of Raman that is useful to 
probe multiple layers of a sample. When using conventional Raman, light is 
scattered back at the same point as the sample was illuminated, so most of the 
signal is from the surface. By using spatially offset Raman spectroscopy (SORS), 
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deeper levels of a sample than would be possible using conventional Raman can 
be probed nondestructively. SORS, discovered by Matousek et al., employs the 
same concepts as normal Raman, except after the sample is illuminated, spectra 
are collected at a point offset from the incident light. 13 As the collection point is 
moved farther from the incident point, the information obtained comes from 
deeper layers. With increased offset from the incident point, the top layer 
contribution is lessened, and contribution from deeper layers is seen. This is 
because of the migration of photons in the subsurface layers before light is 
scattered back out, referred to as the photon migration effect. 13 As light travels 
through the sample, it becomes more evenly dispersed through the subsurface 
layers then it scatters back out, and signal is collected at an offset. When using 
an offset, the spectrum contains more chemical information from subsurface 
layers than from the zero-point offset. 
            As previously stated in Chapter 1, the two types of SORS collection 
include point collection and inverse (concentric circle) collection.14-15 Concentric 
circle collection is easier to do manually and also gives higher collection 
efficiency.15 To achieve an offset, an optical lens called an axicon is used. An 
axicon works by focusing the light into beams that cross the optical axis and form 
a ring. The offset is the radius of the ring, which can be manipulated by varying 
the distance of the axicon from the sample Although the diameter of the ring is 
varied to obtain different offsets, the width of the ring itself is maintained.  
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            Utilizing concentric circle collection SORS will allow for rapid, non-
invasive detection of biomarkers in the eye. Probing the eye non-invasively (i.e. 
without requiring cutting into the eye) will allow for a potential for easier, safer, 
faster diagnosis of diseases such as glaucoma, macular degeneration, blindness, 
etc., as well as provide a method to measure biomarkers of post-mortem interval 
for forensic purposes. Here we present the first instance that we know of showing 
that SORS can be used to ascertain chemical information from different layers in 
multiple locations of the eye. 
3.3 Methods 
 
Fresh bovine eyes (n=2) were purchased from Nebraska Scientific. Eyes 
were immediately subjected to testing upon arrival after being stored on dry ice 
through transit. After removal of excess tissue, each of the whole eyes was 
subject to spatially offset Raman spectroscopy (SORS). A home-built macro-
Raman system with 180-degree backscattering geometry and was used. The 
system was equipped with a 785-nm diode laser, spectrometer (Princeton 
Instruments Acton LS-785), and CCD camera (Princeton Instruments Pixis 400). 
Concentric circle collection was used, with spatial offset created by an axicon 
lens. SORS spectra were measured using 0mm, 2mm, and 5 mm spatial offsets 
through the front, side, and back of each whole eye in order to measure through 
different layers of the eye. Spectra were collected at 25mW of illumination power 
in three 60s frames, totaling 3 minutes of collection time at each spot. After 
spectra were collected from whole eyes, the eyes were dissected, and lenses 
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were isolated. Raman spectra of each lens were taken (785nm, 25mW, 60s, 3 
frames). Data collected was averaged using home-written Matlab code and 
subsequent average spectra were baselined and processed with Grams/AI 
software. 
3.4 Results and Discussion 
Averaged spectra show that through the back of the eyes (Figure 13a and 
d) and the side of the eyes (Figure 13b and e), the peak around 939 cm-1 was 
found in all three spectra for both eyes. This peak is attributed to the C-C stretch 
of the collagen backbone.The vitreous humor, located in the posterior of the eye, 
is known to be comprised mainly of collagen, and this is supported by the 
observation of the 939 cm-1 collagen peak in these spectra. It is seen in these 
spectra that noise is drastically decreased through the 5mm offset, indicating a 
5mm offset would be optimal to minimize noise when measuring posterior 
components of the eye. It is thought that the noise from the 0 and 2mm offset 
spectra arises from the fluorescent nature of the sclera. Measuring through 5mm 
completely passes the contribution from the sclera, resulting in the observation of 








Figure 13. Average SORS Spectra. Average spectra from eye 1 (a-c) and eye 2 (d-f). 
Specrea were measured through the back (a and d), side (b and e), and front (c and f) of 




through the front of the eye show that there are several peaks measured in the 
0mm offset that are not measured in the other offsets. The peak around 939 cm-1 
is measured in all offsets and is again attributed to collagen. Several other peaks 
are seen in the 0mm offset spectra, including peaks around 758 cm-1, 831 cm-1, 
855 cm-1, 883 cm-1, 1005 cm-1, 1034 cm-1, 1241 cm-1, 1341 cm-1, 1450 cm-1, 1550 
cm-1, and 1669 cm-1. Peaks at 1005 cm-1 and 1450 cm-1 were found in the 0 and 
2mm offsets through the front of the eye. To determine where these peaks were 
arising from, spectra from the lens alone were analyzed and a representative 
spectrum is shown in Figure 14. It can be seen that many of the peaks observed 
in the 0mm offset spectra are arising from the lens, indicating that using Raman 
with no offset allowed for the observation of lens through the cornea. It is thought 
that because of the transparency of the cornea, the laser focused straight 
through the cornea onto the lens. It is well known that the eye lens is comprised 
of crystalline proteins. This indicates that the peaks observed are due to proteins. 
Based on literature, several of the peaks in the lens spectra were assigned and 
summarized in Table 1. 10, 16 Peaks from the lens were also found in the 2mm 
offset spectra, so we concluded that we had not fully passed the lens with the 
2mm offset. It is noted that the lens peaks are not observed at the 5mm offset. If 
more studies were to be done, it would be worth studying different depths to 
determine which offset best focuses on the lens. Future work should include 
using multiple other offsets to determine if more chemical differences at different 








Figure 14. Raman Spectrum of Bovine Lens. Lens spectrum collected at 785-nm 




Table 1: Peak Assignments of Lens 
Component  Peaks (cm-1) 
Tryptophan  758, 880 
Tyrosine 834, 855 
Phenylalanine 1005, 1032 




purposes. As this study was just preliminary, more eyes should be studied to 
show that this is indeed reproducible in different samples.  
 
3.4 Conclusions and Future Work 
 
In conclusion, we were able to use SORS to measure through different 
parts of whole bovine eyes non-invasively. Spectra were found to be 
representative of the components known to be in each part of the eye. It was 
shown that a 0mm offset through the front of the eye results in a Raman 
spectrum where several peaks are attributed to the lens proteins, and the 2mm 
spectrum also shows some peaks attributed to the lens. It was shown that 
collagen can be measured through the back and side of the eye, with a 5mm 
offset giving the best S/N ratio. Measuring through the eye could be useful in 
non-invasively and non-destructively diagnosing diseases such as cataracts, 
macular degeneration, and glaucoma. This method should be studied in depth to 
determine optimum offsets for measuring through each part of the eye. The 
maximum power that could be applied to the eye without damaging it should also 
be studied. It is thought that measuring spectra of the lens over time could be a 
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useful tool for disease diagnosis or forensic post-mortem interval analysis. In the 
future, this SORS method could be used to determine trends in chemical 
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This chapter details the use of normal Raman and SORS to measure the 
chemical composition of bone in relation to its healing. Normal Raman and 
SORS were used to find ratios of different components that describe bone 
fracture healing such as the ratios of carbonate/phosphate, carbonate/amid I, 
phosphate/amide I, and the full-width half maximum (FWHM) of phosphate. 
These ratios each tell something about the healing bone, and we aimed to show 
how bone heals over time in the intervals of 1 month, 3 months, 6 months, 9 
months, and 12 months.  
 




4.1 Abstract  
 
Knowledge of the microscopic, physical, and chemical properties of bone 
formation can give insight into how fractured bones will heal or have healed over 
time. It is known that Raman spectroscopy to ascertain chemical ratios 
(matrix/bone, etc.) provide valuable information about bone properties. It is also 
known that bone heals in stages, although it is not well known what the chemical 
composition is at each stage of bone haling. To address this gap in knowledge, 
we used normal Raman and SORS to show that fractured bone does change in 
composition as it heals, and ratios may be able to be used to determine the 
trends in bone healing in order to monitor it in real time also to one day help to 
accurately estimate the age of a bone fracture, especially for application to child 
abuse cases. The overall objective was to establish the chemical composition of 
fractured bone at different stages in the healing process and apply this toward in 
vivo monitoring of bone in real time. It was discovered that ratios change over 
time and could prove to be valuable in determining what stage of healing the 





It is well known that bone tissue is made of two phases, the carbonated 
apatite mineral phase, which contains mineral phosphate and carbonate and the 
organic matrix phase, which contains Type I collagen. 1,2 It is also recognized 
that Raman spectroscopy can be used to determine the composition of bone. 
Figure 15 shows the Raman spectrum of bone. Raman peaks that describe the 
matrix include hydroxyproline (876 cm-1), proline (921 and 855 cm-1), 
phenylalanine (1002 cm-1), amide III (1250 cm-1), CH2 wag at 1447 cm-1, and the 
amide I band at 1667 cm-1. Several Raman peaks describe the mineral 
(inorganic) portion of the bone. These include the phosphate peak around 959 
cm-1 and carbonate around 1070 cm-1. Ratios of peaks seen in the Raman 
spectra of bones reveal crucial information about the bone, described in Table 2. 
 
 
Table 2: Ratios of bone peaks  as described by Morris et al.1 
Chemical Ratio  Description 
Phosphate (959 cm-1)/Amide I (1616-1720 cm-1) Indicates amount of 
mineralization  
Carbonate (1070 cm-1)/Phosphate (959 cm-1) Varies with bone 
architecture, age, and 
crystallinity 
Carbonate (1070 cm-1)/Amide I (1616 -1720 cm-1) May indicate bone 
remodeling 














Figure 15. Raman Spectrum of Bone. Spectrum of 6 week old mouse bone 




Raman spectroscopy has been used extensively to study bone 
composition and healing. Raman spectroscopy has previously been used to 
monitor the healing process in rat bones by Gamulin et al. 3 They studied the 
healing effect of stable gastric pentadecapeptide (BPC157) on rat femoral heads 
and discovered that there was a statistical difference between treated, control, 
and healthy animals indicating a positive influence of BPC on rat bone healing. 
Ding et al. has used spatially-offset Raman spectroscopy (SORS) to look at bone 
fractures in rat bones. 4 In this study, it was observed that the phosphate band at 
960 cm-1 was weaker in fractured bone, which meant there was less 
mineralization in the femur that had been fractured. Hydroxyapatite, proline, and 
carbonate are directly related to the relative amount of mineral and collagen, so 
the peak height ratios of phosphate/proline, carbonate/phosphate, and 
proline/amide III were used to determine the extent of collagen mineralization, 
carbonation, and collagen content, respectively. 4 Feng et al. showed that SORS 
is promising for measuring chemical differences in subcortical bone tissue. 6 The 
ability of SORS to measure through bone was analyzed by putting a known 
substance, Tylenol, behind bone and measuring normal spectra at 0 mm and an 
offset. Tylenol was seen better at an offset, indicating subcortical tissue can be 
measured using SORS. They then studied murine bones with and without 
osteoporosis and observed a noticeable difference, leading to the conclusion that 
normal and diseased bone are different from one another.   
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In our study, normal Raman and SORS was used to analyze bone fracture 
healing at different time intervals ranging from 1 to 12 months. The main 
hypothesis was that chemical ratios shown in Table 2 would change over time. 
We expected changes in the mineral and organic contributions to Raman spectra 
at different intervals of healing. We expected that as a bone heals, more mineral 
is deposited and bone ratios as well as phosphate content discussed in Table 2 
will change due to bone mineralization and remodeling.  
 
4.3 Materials and Methods  
 Goat tibias from 5-year old goats that had been used in a previous study 
were obtained from the University of Tennessee Veterinary School. Animals were 
sacrificed humanely by trained veterinarians at the respective month interval. For 
this work, only controls were used, meaning samples had not been treated with 
drugs and any healing present was natural. We obtained available control 
samples including: one 1-month sample, one 3-month sample, four 6-month 
samples, seven 9-month samples, and four 12-month samples. Samples had 
been stored in a deep freezer at -80 degrees Celsius after collection. Samples 
were thawed on ice before use, and as much blood as possible removed using 
3% hydrogen peroxide. Any excess tissue was removed using dissection tools. 
A microscope at 20X magnification equipped with a camera was used to 
image bones near and far from the fracture line on a bone of each month time 
interval. The spot was focused on the bone by first focusing with the microscope, 
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and then a picture was taken at the spot with 20X magnification. Images were 
taken at points both near and far from the fracture on each bone in order to see 
microscopic structural differences.  
After images were collected on the microscope, bones were subjected to 
spatially offset Raman spectroscopy (SORS). The home-build macro-Raman 
system seen in Figure 8, equipped with a 785-nm laser at 25 mW of power. 
Raman spectra of the bones were collected from each bone at 2-6 spots 
(depending on size of the bone) on each side (proximal or distal) of the bone. 
Bone thicknesses were measured with a micrometer and ranged from 3-10 mm. 
For SORS spectra, offsets were determined by this thickness, with the offset 
being approximately half the thickness of the bone.  
To obtain chemical information from the bones, normal RS spectra of each 
bone were taken at each point depicted in Figure 16 at 0 mm offset and an offset 
determined by choosing an offset of half the thickness of the bone. Collection of 
data from each spot (both no offset and offset) consisted of three frames with 60 
seconds of acquisition time each.  Bones had previously been cut along the 
sagittal plane, which allowed for the collection of what would normally be the 
inside of the bone, with the 0mm offset focusing on the inside part of the bone. 
We collected data from this site of the bone in order to directly measure Raman 









Figure 16. Locations of Data Collection. Data was collected at each spot, 







Spectra were preprocessed by baseline correction and smoothing using 
home-written MatLab code. Spectra were then peakfit with GRAMS/AI software 
(ThermoScientific). An example of this is shown in Figure 17. Peak fitting allowed 
for determining the integrated peak areas for the major components of bone. 
After peak-fitting each spot of the bone, data was normalized. To normalize data, 
the data from the non-fractured part of the bone was first peak-fit and averaged. 
It was seen that the phenylalanine peak at approximately 1002 cm-1 remained 
the most constant between samples, and there is no evidence of changes in 
phenylalanine concentration with healing in the literature, so we chose to 
normalize to the phenylalanine peak. After peakfitting the normal bone data, the 
spectra near the fracture were peak-fit. Then normalization factors were 
calculated for each spot away from the fracture and spectra were normalized by 
dividing by the normalization factor. Normalized spectra were then peakfit and 
integrated areas of major components of bone were calculated. These areas 










Figure 17. Peak-Fit Spectrum. Example of how spectra were peak-fit. Peaks were 






 Statistics were used to determine significant differences in data.  One-way 
analysis of variance (ANOVA) tests are used when determining if there are 
statistically significant differences between the means of 2 or more independent 
groups. This test was used in this study to determine statistically significant 
differences between the means of the 1,3,6,9, and 12- month samples. ANOVAs 
were performed in Statistical Product and Service Solutions (SPSS) for each of 
the four chemical ratios at each bone location (distal near side, distal far side, 
proximal near side, proximal far side). The detailed results of these ANOVAs can 
be found in the Appendix.  
 ANOVA testing only tells that there is a difference and not where the 
difference lies between samples, therefore, a post-hoc test is necessary to 
establish which samples were statistically different. For this test, we utilized the 
Tukey honest significant difference, also carried out by SPSS software. The 
Tukey test compares differences between means of values and identifies where 
there are significant differences. Differences were considered significant when p 
<0.05.   
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4.4 Results and Discussion  
Figure 18 shows photos taken on the microscope both near and far from 
the fracture site. Visible differences are observed between the structure of 
normal and fractured bone on a microscopic scale. Particularly, it is seen that the 
6-month bone looks more like a webbed structure near the fracture than the 
structure of normal bone. It was concluded that bone near the fracture line looks 
more like woven bone than lamellar bone, which is reasonable because woven 
bone is characteristic of bone remodeling. Woven bone is the first bone laid down 
after a fracture and is characterized by collagen fiber. The woven bone is 
gradually replaced by lamellar bone, so it would be reasonable to see woven 
bone in the fractured areas of the bone.6 Although microscope images provided 
some information about the bone structure, they did not provide quantitative 
information, so it was determined that chemical information would be beneficial in 
understanding what is happening at a molecular level that could differentiate 












Figure 18. Photos of normal and fractured goat tibia samples. The boxes indicate 
spots where the magnified images were collected on the normal bone and near 





Average chemical ratios from normalized spectra are depicted in Figures 
19-22. Pooled standard deviations (see Appendix) are shown by error bars, 
calculated based on how many frames of data had been averaged for that 
month’s interval. Figure 19a shows that on the side near to the fracture on the 
distal bones, phosphate/amide I ratio increased at 6 months, decreased again at 
9 months, and then slightly increased at 12 months, and on the far side of the 
bone, there was an initial decrease, then an increase at 6 months, and then a 
continued decrease in phosphate/amide I. At 6 months, the ratio was interesting 
similar in the near and far sides of the distal bones.  
In order to determine if these trends were significant, an analysis of 
variance (ANOVA) was conducted on each part of the bone (distal far side, distal 
near side, proximal far side, proximal near side) to determine if the changes seen 
between months were significant. The ANOVA of the far distal side of the bone 
for the phosphate/amide I ratio was (F(4,18)=10.884,p=0.000) and the ANOVA 
for the near side of the distal bone was (F(4,18)= 3.692,p=0.023) indicating there 
were significant differences between months on both sides of the distal bone. To 
further determine where the differences lie, a Tukey test (Tukey’s Honest 
Significant Difference test) was conducted. The Tukey test showed, as seen in 
Figure 19, that there was a significant change between 1 and 3 months (p 
=0.005), 6 and 12 months (p=0.015), 1 and 9 months (p=0.001), and 1 and 12 
months (p<0.001) for the far side of the distal bone, indicating changes seen in 
phosphate/amide I ratio were significant. There was also a significant difference 
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between 6 and 9 months (p=0.018) for the near side of the distal bone, indicating 
a significant change in mineralization.  
Figure 19b shows the phosphate/amide I ratio trend for the proximal side 
of the bone. On the near fracture side of the proximal bone, there was a steady 
decrease of phosphate/amide I ratio through the 12 months. On the far side of 
the proximal bones, there was a decrease from 3 to 6 to 9 months, and then an 
increase. Again, around 6 months the ratios were near the same. After 
conducting an ANOVA for both near and far sides of the proximal (F(4,18)=2.444, 
p=0.084) and (F(4,16)=1.068, p=0.404), respectively, it was determined that 
there were no significant differences on the proximal side of the bone, although 
there did seem to be a decrease in phosphate/amide I ratio over time. Based on 
the trends observed here, it can be determined that phosphate/amide I ratio 
changes as bone heals, indicating changes in mineralization, with significant 












          
Figure 19. Average Phosphate/Amide I Ratio Over Time. Average 
phosphate (960 cm-1)/Amide I (1660 cm-1) ratios of normalized, peakfit data 
per month. A) Distal side shows the trend over the 12 months for the distal 
side of the bone and B) Proximal shows the trend over 12 months for the 
proximal side of the bone. Significant differences (p<0.05) shown by brackets 
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Figure 20a shows that on the side near to the fracture on the distal bones, 
carbonate/phosphate ratio slightly increased at 3 months, then decreased over 
time. On the far side of the bone, there was an initial increase, then a decrease 
between 3 and 9 months, and then a sharp increase at 12 months, indicating the 
architecture of the bone at 12 months on the far side was different than the near 
side, having more carbonate to phosphate.  The ANOVA for the 
carbonate/phosphate ratio on the far side of the distal bone indicated a significant 
difference between months (F(4,18)= 5.154,p=0.006). As seen in Figure 20a, 
Tukey test indicated the significant difference between months was found 
between 1 and 3 months (p=0.048), 6 and 12 months (p=0.05), 9 and 12 months 
(p=0.05), and 1 and 12 months (p=0.01) on the far side of the distal bone. An 
ANOVA test of the near side of the distal bone indicated a significant difference 
between months (F(4,18)= 3.091,p=0.042). The Tukey test indicated a significant 
difference between 3 and 12 months (p= 0.05).  
Figure 20b shows the carbonate/phosphate ratio trend for the proximal 
side of the bone. On the near fracture side of the proximal bone, there was an 
initial decrease at 3 months, and then an increase from 6 to 9 months, and a very 
slight decrease at 12 months. The end ratio on the near side of the proximal 
bone was slightly lower than the initial ratio, but not greatly changed. The end 
ratio on the far side of the proximal bone was lower than the initial ratio at 1 
month. On the near distal side, there was a decrease in this ratio overall, but as 
opposed to the far proximal side, the far distal side had increased in this ratio. 
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ANOVAs of the near and far sides of the proximal bone (F(4,18) = 0.555, 
p=0.698) and (F(4,16)=0.732, p=0.583) indicated no significant differences 
between months in the proximal side of the bone. These results would indicate 
that the proximal and distal sides could be different from each other and this 
would require further investigation. It could be determined that there is, however 
a slight decrease in the carbonate/phosphate ratio near the fracture over time in 
both sides of the bone, with significant differences being observed in the distal 
side of the bone.  
Figure 21a shows that on the side near to the fracture on the distal bones, 
carbonate/amide I ratio clearly decreases at 6 and 9 months and increases again 
at 12 months. The same trend is true for the far side of the bone. ANOVAs of the 
near and far sides of the bone indicated significant differences, with (F(4,18) = 
11.547,p<0.000) and (F(4,18)=10.168,p<0.000), respectively. A Tukey test of the 
near side of the bone indicated a significant difference between 6 and 9 months 
(p=0.013), which is of particular interest in this study, as remodeling is thought to 
occur around 6 to 9 months and carbonate/amide I is indicative of remodeling. 
The Tukey test also indicated a significant difference between 3 and 12 months 
(p=0.017), indicating remodeling had taken place during this time. 
On the proximal side of the bone, shown in Figure 21b, there was a clear 
decrease in the carbonate/amide I ratio over time on both the near and far sides 
of the bone. ANOVAs of the far and near sides of the proximal bone indicated no 











Figure 20. Average Carbonate/Phosphate Ratio Over Time . Average 
carbonate (1070 cm-1) /phosphate (960 cm-1) ratios of normalized, peakfit data 
per month. A) Distal shows the trend over the 12 months for the distal side of 
the bone and B) Proximal shows the trend over 12 months for the proximal 
side of the bone. Significant differences (p<0.05) shown by brackets 




































difference between months on the near side (F(4,18) =6.148, p=0.003). The 
Tukey test of the proximal near side indicated the significant difference was 
between 1 and 9 months (p=0.004) and 1 and 12 months (p=0.013). The trends 
observed here indicate that there is a decrease in carbonate/amide I ratio as 
bone heals, and this could be the most optimal ratio to use to estimate age of a 
fracture, as there is a clear decrease at 6-9 months on the distal side, which is 
where remodeling is thought to occur.  
Figure 22a shows that on the side near to the fracture on the distal bones, 
the FWHM of phosphate does not change too much, although there is a slight 
increase in the near side at 3 months, and a decrease in the far side at 3 months. 
ANOVAs of the near and far sides of the distal bone indicate a significant 
difference on the far side (F(4,18) =5.240,p=0.006) and no significant difference 
on the near side of the distal bone (F(4,18) =2.037,p=0.132). The significant 
differences on the far side were found by the Tukey test to be from 1 to 3 months 
(p=0.026) and 1 to 12 months (p=0.011). These results indicate there was a 
significant change in crystallinity on the far side of the distal bone and no 
significant change in crystallinity on the near side. 
In the proximal side of the bone, shown in Figure 22b, there is an increase 
in both the near and far side at 3 months and then a steady slight decrease. 
ANOVAs of the near and far sides of the proximal bone indicated significant 
differences between months on both near and far sides of the proximal bone with 












Figure 21. Average Carbonate/Amide I Ratio Over Time. Average carbonate 
(1070 cm-1)/Amide I (1660 cm-1) ratios of normalized, peakfit data per month. A) 
Distal side shows the trend over the 12 months for the distal side of the bone 
and B) Proximal shows the trend over 12 months for the proximal side of the 
bone. Significant differences (p<0.05) shown by brackets corresponding to near 
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tests indicated that on the near side of the proximal bone, statistically significant 
differences were observed from 1 to 3 months (p=0.004), 3 to 6 months 
(p=0.041), and 1 to 12 months (p=0.048). On the far side of the proximal bone, 
the Tukey test indicated a statistically significant difference from 3 to 12 months 
(p=0.027). These results indicate that on the proximal side of the bone, there 
were statistically significant changes in crystallinity over time.  
4.5 Conclusions and Future Work 
 It is clearly shown here that there are chemical changes over time in bone 
that has been fractured. The phosphate/amide I ratio showed changes over time, 
with both the proximal and distal sides showing a decrease around 6 months, 
indicating the mineral to matrix ratio is lower at this time. This result supported 
that remodeling may be occurring at 6 months. The carbonate/phosphate ratio 
showed us that there were changes, but the proximal and distal sides seemed to 
be different from each other, and there were no significant differences on the 
proximal side. This could lead the way into new investigations as to if the 
proximal and distal sides of the bone are indeed different in their carbonate 
composition. The carbonate/amide I ratio showed a similar trend in both the 
proximal and distal sides of the bone, with a statistically significant difference 
occurring between 6 and 9 months on the distal side. This showed that there was 
remodeling taking place, and we expect that the carbonate/amide I ratio would be 
best for estimating age of fracture. The FWHM did not change drastically over 









     
Figure 22. Average FWHM Ratio Over Time. Average full width at half 
maximum values of the phosphate (960 cm-1) peak of normalized spectra at 
different months A) Distal shows the trend over the 12 months for the distal 
side of bones and B) Proximal shows the trend over the 12 months for the 
proximal side of the bone. Significant differences (p<0.05) shown by brackets 


















































 Table 3: Summary of  statistically significant  ratio differences between 
months  








Phosphate (959 cm-1)/ 
Amide I (1616-1720 cm-1) 
Far Side:      
  1 and 3 months 
  1 and 9 months 
  1 and 12 months 
  6 and 12 months 
 
Near Side: 












Carbonate (1070 cm-1) 
/Phosphate (959 cm-1) 
Far Side:      
  1 and 3 months 
  6 and 12 months 
  9 and 12 months 
  1 and 12 months 
 
Near Side: 











Carbonate (1070 cm-1)/ 
Amide I (1616 -1720 cm-1) 
Far Side:      
  1 and 9 months 
  6 and 9 months 




  6 and 9 months 
  3 and 12 months 
Far Side:      
  None 





  1 and 9 months  





FWHM of phosphate  
(959 cm-1) 
Far Side:      
  1 and 3 months 
  1 and 12 months 




  None 
 
Far Side:      
  3 and 12 months 





  1 and 3 months  
  3 and 6 months  




 It may be noted that offset results have not been shown. Some results 
were processed, but the offset data showed that there was variability within a 
sample. We would need to further optimize the method in order to accurately use 
an offset to determine age of fracture. However, we were able to measure 
different chemical signals than the top layer using SORS so the theoretical use of 
SORS itself was validated. We also did not try to measure through the part of the 
bone that would be on layer just beneath the skin, so we would need to try to use 
SORS through that part of the bone. For this study’s purposes, it was shown that 
Raman and SORS can be used to describe the chemical composition of bone 
and bone changes in composition through the healing process. Future work 
would include further studying if the proximal and distal sides are different in their 
carbonate content and why, coming up with a better method of SORS to 
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As the technique of Raman spectroscopy is nondestructive, specific, and 
portable, it is desirable to forensic investigators, as it is imperative that evidence 
is preserved as best as possible. Raman spectroscopic techniques have begun 
to be widely used in the area of forensic science, although there is more research 
to be done into how else this method can be used in this field.  The work 
presented here shows more ways Raman spectroscopy can be used to improve 
the field of forensic science.  
First, we determined which biomarkers could be targeted using our 
surface enhanced Raman spectroscopy (SERS) method. We used both gold and 
silver nanoparticles to determine which would be optimum for studying the 
biomolecules of interest. It was determined that phenylalanine was likely the best 
target, as it gave a strong SERS signal with both instrumentation systems as well 
as both gold and silver nanoparticles. Phenylalanine has an easily detectable 
Raman spectrum, which would make this the analyte we would target first in 
biological systems.  Tryptophan and tyrosine also gave a strong SERS signal, 
but they would need to be detected with AuNPs. Alanine and proline gave strong 
signal when detected using AgNPs on the macro-system. With AuNPs, less 
power is used and gold is less toxic than silver, leading to the conclusion that 
using AuNPs to measure amino acids, specifically phenylalanine, in vivo would 
be the logical choice to measure biomarkers of post-mortem interval. Future work 
in this area would include optimizing our SERS method with regards to 
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nanoparticle parameters such as size and shape, pH, and time samples are 
incubated. 
We were interested in studying biomarkers in the eye post-mortem in 
order to be able to study time since death or post-mortem interval (PMI). We 
successfully used SORS to measure through the eye. We were able to measure 
the spectra of the lens of the eye noninvasively by using a 0mm offset. The lens 
of the eye gave a distinctive Raman spectrum, with the phenylalanine peak being 
the most prominent. We measured through the front, side, and back of the eye 
using multiple different offsets. It was determined that to measure through the 
side and back of the eye, a 5mm offset was optimum because of its improved 
signal to noise ratio compared to the other offsets. Measuring through the eye 
could prove to be useful in not only determining time of death but also in 
diagnosing and evaluating eye disease such as glaucoma. Future work in this 
area would include collecting data from more samples and collecting data over 
time. The lens is of particular interest for determining post-mortem interval since 
it gives such a distinctive Raman spectrum. The lens would need to be studied 
over time to see how the phenylalanine and other peaks change. It is thought 
that a mathematical model of the phenylalanine change over time could be used 
to estimate time since death. This SORS method would also need to be 
implemented in a portable system and tried in the field.  
We also studied how fractured bone composition changes as bones heal. 
We studied bones that had been previously fractured surgically and allowed to 
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heal over 1,3,6,9, or 12 months. We collected normal Raman and SORS spectra 
on parts of the bone both near and far from the fracture and then normalized the 
data to the spots far from the fracture. After normalizing data, chemical ratios 
were calculated using peak areas. It was determined that chemical composition 
changes over time as bones heal. The phosphate/amide I peak ratio showed 
changes over time, with there being a decrease around 6 months in both the 
proximal and distal sides of the bone, indicating the mineral to matrix ratio is 
lower at this time, where bone remodeling is likely occurring. The 
carbonate/phosphate ratio showed that the proximal and distal side followed 
different trends. It would need to be investigated more to see if the composition is 
different on the opposite sides of the bone. The carbonate/amide I ratio is likely 
the best ratio to use to estimate age of fracture, as the carbonate/amide I ratio 
showed a consistent trend over time. As time went on, the carbonate/amide I 
ratio, which has previously been thought to be indicative of bone remodeling, 
decreased, and there was a statistically significant difference from 6-9 months, 
which is where remodeling is hypothesized to occur. It could be useful to 
mathematically model this decrease over time and create a model where a bone 
fracture of unknown age’s carbonate/amide I ratio is determined and then the 
mathematical model used to predict the age of the fracture. The FWHM of 
phosphate showed little change in crystallinity over time, but there was a 
statistically significant change on the proximal side. Future work in this area 
would include developing a better method to use SORS through bone, measuring 
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SORS spectra through the side of the bone that would be under the skin 
normally, modeling this method using other species, and collecting data from 
more bone samples. Future work could also include collecting SORS spectra 
through the skin in vivo to determine chemical changes over time in a living 
organism. Ultimately, it would be desirable to create models to estimate age of 
fracture in both in vivo and ex vivo samples. 
Overall, these investigations shed light into other ways SORS can be used 
in the forensics field. There is much method development to be completed, but 
these studies showed the versatility of SORS in this field and the promise it has 








STATISTICAL TESTING  
Here we show the results from statistical testing of the bone samples in 
Chapter 4. Each location on the bone (distal near side, distal far side, proximal 
near side, proximal far side) was subjected to a one-way Analysis of Variance 
(ANOVA) test at alpha =0.05. The one and three month samples only had one 
sample, so data input into SPSS was from each frame of data. The ratios for 
each bone from the six, nine, and twelve month samples were calculated by the 
averages of the frames, and then the averages were calculated for each month 
interval. The data input into SPSS for the six, nine, and twelve month samples 
was the average of the average ratios of each month interval. Therefore, the 
standard deviation shown in the descriptives table does not show the pooled 
standard deviation, as was shown on the figures, but rather the standard 
deviation of the averages. Each ANOVA test is shown below. After ANOVA 
testing, samples were subject to a post-hoc test, the Tukey honest significant 
difference (Tukey HSD) test to see where significant differences lay in the data. 
The results of the Tukey tests are also shown below. Results were considered 










AVERAGES Near (n=6) S.D. Far (n=6) S.D. AVERAGES Near (n=6) S.D. Far (n=6) S.D.
Phosphate/AmideI 13.5111332 1.467088071 19.62154 2.427094067 Phosphate/Amide I 14.9553 3.9879 17.89162 6.871864
Carbonate/Phosphate 0.269760522 0.007739851 0.19077 0.027778703 Carbonate/Phosphate 0.2607 0.0042 0.263819 0.016037
Carbonate/Amide I 3.64902602 0.447180899 3.688978 0.166008635 Carbonate/Amide I 3.8935 1.0090 4.666903 1.689502
FWHM Phosphate 22.01137483 0.211439399 23.63317 1.75458053 FWHM Phosphate 21.6292 0.1246 21.43502 0.663503
3 month Average
Distal Proximal
AVERAGES Near (n=3) S.D. Far (n=3) S.D. AVERAGES Near (n=3) S.D. Far (n=3) S.D.
Phosphate/AmideI 13.72914296 2.53188447 12.14428 0.221117897 Phosphate/AmideI 15.64714768 0.059535492 17.72496 0.025434
Carbonate/Phosphate 0.295619168 0.047121037 0.293857 0.015040686 Carbonate/Phosphate 0.221488951 0.005334799 0.204783 0.001034
Carbonate/Amide I 3.979097135 0.035618404 3.56768 0.164497036 Carbonate/Amide I 3.465511527 0.07028793 3.629754 0.013126
FWHM Phosphate 22.33868133 2.225394061 20.24466 0.186762698 FWHM Phosphate 25.2735225 0.318887481 24.2618 0.079131
6 month Average
Distal Proximal 
AVERAGES Near (n=24) S.D. Far (n=24) S.D. AVERAGES Near (n=24 S.D. Far (n=22) S.D.
Phosphate/Amide I 17.22156509 1.698033816 17.19836 0.62796941 Phosphate/Amide I 14.10680161 2.337010243 13.72779 1.679247
Carbonate/Phosphate 0.210661098 0.017016157 0.204742 0.019225937 Carbonate/Phosphate 0.228725162 0.018615662 0.25516 0.022034
Carbonate/Amide I 3.377915027 0.218259723 3.421462 0.06924665 Carbonate/Amide I 3.038963689 0.360520532 3.158102 0.178825
FWHM Phosphate 21.36055208 0.138261039 22.76429 0.423074337 FWHM Phosphate 22.41055048 0.430269898 21.99719 0.319745
9 Month Average 
Distal Proximal
AVERAGES Near (n=39) S.D. Far (n=37) S.D. AVERAGES Near (n=36) S.D. Far (n=38) S.D.
Phosphate/Amide I 11.20724864 1.120065453 12.55653 0.913046198 Phosphate/Amide I 11.42434853 1.609143326 12.08138 0.968405
Carbonate/Phosphate 0.24316339 0.034954637 0.215792 0.027605201 Carbonate/Phosphate 0.247251512 0.036790359 0.277599 0.049135
Carbonate/Amide I 2.448404161 0.085618522 2.525073 0.081642631 Carbonate/Amide I 2.427124162 0.152810534 2.729618 0.142633
FWHM Phosphate 21.07201576 0.14984499 21.52749 0.401424872 FWHM Phosphate 21.40351031 0.238322458 21.10993 0.423308
12 Month Average
Distal Proximal
AVERAGES Near (n=18) S.D. Far (n=17) S.D. AVERAGES Near (n=15) S.D. Far (n=18) S.D.
Phosphate/Amide I 16.03563042 1.96051888 10.18304 0.505544541 Phosphate/Amide I 10.23155845 1.135501216 17.61515 2.504877
Carbonate/Phosphate 0.17935339 0.010750408 0.315489 0.094130383 Carbonate/Phosphate 0.223583551 0.018220508 0.189054 0.017007
Carbonate/Amide I 2.805272248 0.235224573 3.133372 0.602543286 Carbonate/Amide I 2.291127475 0.109510852 3.220361 0.302566
FWHM Phosphate 20.87714628 0.149811392 21.1702 1.182184701 FWHM Phosphate 18.99292416 0.21896735 19.83083 0.266142
Table 1. Averaged data from bone samples, where n = number of frames. S.D is 
standard deviation; S.D. for 6,9, and 12 month samples are pooled standard 
deviations as there were multiple bones.  
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Distal Near Side  
 
Table 2. Descriptive statistics of distal near side bone  
 N Mean Std. Deviation Std. Error 
95% Confidence 
































































1 6 .2697605 .00773985 .00315978 .261638
0 
.2778830 .26004 .28069 
3 3 .2956192 .04712104 .02720534 .178564
0 
.4126743 .24128 .32528 
6 4 .2106611 .04234968 .02117484 .143273
3 
.2780489 .17713 .27243 
9 7 .2431634 .07225114 .02730836 .176342
2 
.3099845 .19191 .40177 
12 3 .1793534 .01862615 .01075381 .133083
5 





.2429682 .05683915 .01185178 .218389
1 
.2675473 .16203 .40177 
Carbonate 
AmideI 
1 6 3.6490260 .44718090 .18256084 3.17973
84 
4.1183136 3.12350 4.30698 
3 3 3.9790971 .03561840 .02056430 3.89061
61 
4.0675782 3.94781 4.01786 
6 4 3.3779150 .59051212 .29525606 2.43827
85 





         
 
9 7 2.4484042 .22832241 .08629776 2.23724
12 
2.6595672 2.07768 2.77910 
12 3 2.8052722 .54038025 .31198868 1.46289
33 





3.1694675 .69094515 .14407202 2.87068
05 



























































Table 3. Analysis of Variance (ANOVA) output for distal near side bone 
 
Sum of 
Squares df Mean Square F Sig. 
PhosphateAmideI Between Groups 109.391 4 27.348 3.692 .023 
Within Groups 133.326 18 7.407   
Total 242.717 22    
CarbonatePhosphate Between Groups .029 4 .007 3.091 .042 
Within Groups .042 18 .002   
Total .071 22    
CarbonateAmideI Between Groups 7.558 4 1.889 11.547 .000 
Within Groups 2.945 18 .164   
Total 10.503 22    
FWHMPhosphate Between Groups 6.202 4 1.550 2.037 .132 
Within Groups 13.700 18 .761   







Table 4. Multiple comparisons test using Tukey HSD for distal near side 
Tukey HSD   
Dependent Variable (I) Month (J) Month 
Mean 
Difference (I-
J) Std. Error Sig. 





PhosphateAmideI 1 3 -.21800976 1.9244474
6 
1.000 -6.0371459 5.6011264 
6 -3.71043189 1.7567721
4 
.258 -9.0225521 1.6016883 
9 2.30388456 1.5141471
6 
.562 -2.2745873 6.8823564 
12 -2.52449722 1.9244474
6 
.688 -8.3436333 3.2946389 
3 1 .21800976 1.9244474
6 
1.000 -5.6011264 6.0371459 
6 -3.49242213 2.0786408
3 
.470 -9.7778075 2.7929632 
9 2.52189432 1.8780684
2 
.669 -3.1570010 8.2007897 
12 -2.30648746 2.2221605
2 
.835 -9.0258471 4.4128721 
6 1 3.71043189 1.7567721
4 
.258 -1.6016883 9.0225521 
3 3.49242213 2.0786408
3 
.470 -2.7929632 9.7778075 
9 6.01431645* 1.7058403
5 
.018 .8562036 11.1724293 
12 1.18593467 2.0786408
3 
.978 -5.0994507 7.4713200 
9 1 -2.30388456 1.5141471
6 
.562 -6.8823564 2.2745873 
3 -2.52189432 1.8780684
2 
.669 -8.2007897 3.1570010 
6 -6.01431645* 1.7058403
5 
.018 -11.1724293 -.8562036 
12 -4.82838178 1.8780684
2 
.118 -10.5072771 .8505136 
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12 1 2.52449722 1.9244474
6 
.688 -3.2946389 8.3436333 
3 2.30648746 2.2221605
2 
.835 -4.4128721 9.0258471 
6 -1.18593467 2.0786408
3 
.978 -7.4713200 5.0994507 
9 4.82838178 1.8780684
2 
.118 -.8505136 10.5072771 
CarbonatePhosphat
e 
1 3 -.02585865 .03421177 .940 -.1293081 .0775908 
6 .05909942 .03123093 .356 -.0353365 .1535354 
9 .02659713 .02691768 .857 -.0547964 .1079907 
12 .09040713 .03421177 .104 -.0130423 .1938565 
3 1 .02585865 .03421177 .940 -.0775908 .1293081 
6 .08495807 .03695294 .190 -.0267801 .1966962 
9 .05245578 .03338727 .533 -.0485005 .1534121 
12 .11626578 .03950435 .059 -.0031873 .2357189 
6 1 -.05909942 .03123093 .356 -.1535354 .0353365 
3 -.08495807 .03695294 .190 -.1966962 .0267801 
9 -.03250229 .03032549 .818 -.1242004 .0591958 
12 .03130771 .03695294 .912 -.0804304 .1430458 
9 1 -.02659713 .02691768 .857 -.1079907 .0547964 
3 -.05245578 .03338727 .533 -.1534121 .0485005 
6 .03250229 .03032549 .818 -.0591958 .1242004 
12 .06381000 .03338727 .347 -.0371463 .1647663 
12 1 -.09040713 .03421177 .104 -.1938565 .0130423 
3 -.11626578 .03950435 .059 -.2357189 .0031873 
6 -.03130771 .03695294 .912 -.1430458 .0804304 
9 -.06381000 .03338727 .347 -.1647663 .0371463 
CarbonateAmideI 1 3 -.33007112 .28603191 .776 -1.1949732 .5348310 
6 .27111099 .26111022 .834 -.5184330 1.0606550 
9 1.20062186* .22504871 .000 .5201205 1.8811232 
12 .84375377 .28603191 .058 -.0211483 1.7086559 
3 1 .33007112 .28603191 .776 -.5348310 1.1949732 
6 .60118211 .30894978 .330 -.3330189 1.5353831 
9 1.53069297* .27913856 .000 .6866350 2.3747510 
12 1.17382489* .33028120 .017 .1751220 2.1725278 






6 1 -.27111099 .26111022 .834 -1.0606550 .5184330 
3 -.60118211 .30894978 .330 -1.5353831 .3330189 
9 .92951087* .25354019 .013 .1628571 1.6961646 
12 .57264278 .30894978 .376 -.3615583 1.5068438 
9 1 -1.20062186* .22504871 .000 -1.8811232 -.5201205 
3 -1.53069297* .27913856 .000 -2.3747510 -.6866350 
6 -.92951087* .25354019 .013 -1.6961646 -.1628571 
12 -.35686809 .27913856 .707 -1.2009261 .4871899 
12 1 -.84375377 .28603191 .058 -1.7086559 .0211483 
3 -1.17382489* .33028120 .017 -2.1725278 -.1751220 
6 -.57264278 .30894978 .376 -1.5068438 .3615583 
9 .35686809 .27913856 .707 -.4871899 1.2009261 
FWHMPhosphate 1 3 -.32730650 .61689120 .983 -2.1926595 1.5380465 
6 .65082275 .56314205 .775 -1.0520038 2.3536493 
9 .93935907 .48536740 .335 -.5282928 2.4070110 
12 1.13422856 .61689120 .383 -.7311245 2.9995816 
3 1 .32730650 .61689120 .983 -1.5380465 2.1926595 
6 .97812925 .66631866 .595 -1.0366823 2.9929408 
9 1.26666557 .60202417 .261 -.5537326 3.0870637 
12 1.46153506 .71232461 .282 -.6923891 3.6154592 
6 1 -.65082275 .56314205 .775 -2.3536493 1.0520038 
3 -.97812925 .66631866 .595 -2.9929408 1.0366823 
9 .28853632 .54681561 .983 -1.3649224 1.9419951 
12 .48340581 .66631866 .948 -1.5314057 2.4982174 
9 1 -.93935907 .48536740 .335 -2.4070110 .5282928 
3 -1.26666557 .60202417 .261 -3.0870637 .5537326 
6 -.28853632 .54681561 .983 -1.9419951 1.3649224 
12 .19486948 .60202417 .997 -1.6255287 2.0152676 
12 1 -1.13422856 .61689120 .383 -2.9995816 .7311245 
3 -1.46153506 .71232461 .282 -3.6154592 .6923891 
6 -.48340581 .66631866 .948 -2.4982174 1.5314057 
9 -.19486948 .60202417 .997 -2.0152676 1.6255287 
*. The mean difference is significant at the 0.05 level. 







Distal Far Side  
 
Table 5. Descriptive statistics of distal far side bone 










































































































































































































































































Table 5 Continued 
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Table 6. Analysis of Variance (ANOVA) output for distal far side bone 
 
Sum of 
Squares df Mean Square F Sig. 
PhosphateAmideI Between Groups 282.788 4 70.697 10.884 .000 
Within Groups 116.923 18 6.496   
Total 399.711 22    
CarbonatePhosphate Between Groups .047 4 .012 5.154 .006 
Within Groups .041 18 .002   
Total .089 22    
CarbonateAmideI Between Groups 5.238 4 1.310 10.168 .000 
Within Groups 2.318 18 .129   
Total 7.557 22    
FWHMPhosphate Between Groups 43.601 4 10.900 5.240 .006 
Within Groups 37.441 18 2.080   








Table 7. Multiple comparisons test using Tukey HSD for distal far side  








J) Std. Error Sig. 





PhosphateAmideI 1 3 7.47725680* 1.8021826
9 
.005 2.0278244 12.9266892 
6 2.42317824 1.6451601
8 
.592 -2.5514502 7.3978067 
9 7.06500360* 1.4179497
5 
.001 2.7774131 11.3525941 
12 9.43849937* 1.8021826
9 
.000 3.9890670 14.8879318 
3 1 -7.47725680* 1.8021826
9 
.005 -12.9266892 -2.0278244 
6 -5.05407856 1.9465797
8 
.113 -10.9401383 .8319812 
9 -.41225320 1.7587502
1 
.999 -5.7303547 4.9058483 
12 1.96124257 2.0809813
2 
.877 -4.3312200 8.2537051 
6 1 -2.42317824 1.6451601
8 
.592 -7.3978067 2.5514502 
3 5.05407856 1.9465797
8 
.113 -.8319812 10.9401383 
9 4.64182536 1.5974642
1 
.063 -.1885802 9.4722309 
12 7.01532113* 1.9465797
8 
.015 1.1292614 12.9013809 
9 1 -7.06500360* 1.4179497
5 
.001 -11.3525941 -2.7774131 
3 .41225320 1.7587502
1 
.999 -4.9058483 5.7303547 
6 -4.64182536 1.5974642
1 
.063 -9.4722309 .1885802 
12 2.37349577 1.7587502
1 
.665 -2.9446057 7.6915973 
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12 1 -9.43849937* 1.8021826
9 
.000 -14.8879318 -3.9890670 
3 -1.96124257 2.0809813
2 
.877 -8.2537051 4.3312200 
6 -7.01532113* 1.9465797
8 
.015 -12.9013809 -1.1292614 
9 -2.37349577 1.7587502
1 
.665 -7.6915973 2.9446057 
CarbonatePhosphat
e 
1 3 -.10308728* .03388717 .048 -.2055552 -.0006194 
6 -.01397204 .03093461 .991 -.1075120 .0795679 
9 -.02502259 .02666228 .878 -.1056439 .0555987 
12 -.12471944* .03388717 .013 -.2271873 -.0222516 
3 1 .10308728* .03388717 .048 .0006194 .2055552 
6 .08911524 .03660233 .151 -.0215627 .1997932 
9 .07806469 .03307049 .172 -.0219337 .1780631 
12 -.02163216 .03912953 .980 -.1399519 .0966876 
6 1 .01397204 .03093461 .991 -.0795679 .1075120 
3 -.08911524 .03660233 .151 -.1997932 .0215627 
9 -.01105055 .03003777 .996 -.1018786 .0797775 
12 -.11074740* .03660233 .050 -.2214254 -.0000694 
9 1 .02502259 .02666228 .878 -.0555987 .1056439 
3 -.07806469 .03307049 .172 -.1780631 .0219337 
6 .01105055 .03003777 .996 -.0797775 .1018786 
12 -.09969686 .03307049 .051 -.1996953 .0003016 
12 1 .12471944* .03388717 .013 .0222516 .2271873 
3 .02163216 .03912953 .980 -.0966876 .1399519 
6 .11074740* .03660233 .050 .0000694 .2214254 
9 .09969686 .03307049 .051 -.0003016 .1996953 
CarbonateAmideI 1 3 .12129873 .25376847 .988 -.6460453 .8886428 
6 .26751618 .23165786 .776 -.4329699 .9680022 
9 1.16390489* .19966397 .000 .5601618 1.7676480 
12 .55560676 .25376847 .228 -.2117373 1.3229508 
3 1 -.12129873 .25376847 .988 -.8886428 .6460453 
6 .14621745 .27410128 .983 -.6826088 .9750437 
9 1.04260617* .24765267 .004 .2937551 1.7914573 
12 .43430803 .29302659 .586 -.4517445 1.3203606 
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6 1 -.26751618 .23165786 .776 -.9680022 .4329699 
3 -.14621745 .27410128 .983 -.9750437 .6826088 
9 .89638872* .22494171 .007 .2162109 1.5765665 
12 .28809058 .27410128 .828 -.5407357 1.1169169 
9 1 -1.16390489* .19966397 .000 -1.7676480 -.5601618 
3 -1.04260617* .24765267 .004 -1.7914573 -.2937551 
6 -.89638872* .22494171 .007 -1.5765665 -.2162109 
12 -.60829814 .24765267 .145 -1.3571492 .1405530 
12 1 -.55560676 .25376847 .228 -1.3229508 .2117373 
3 -.43430803 .29302659 .586 -1.3203606 .4517445 
6 -.28809058 .27410128 .828 -1.1169169 .5407357 
9 .60829814 .24765267 .145 -.1405530 1.3571492 
FWHMPhosphate 1 3 3.41501867* 1.0198178
6 
.026 .3312977 6.4987396 
6 .89538575 .93096208 .869 -1.9196535 3.7104250 
9 2.13218341 .80238841 .101 -.2940753 4.5584421 
12 3.82884790* 1.0198178
6 
.011 .7451269 6.9125689 
3 1 -3.41501867* 1.0198178
6 
.026 -6.4987396 -.3312977 
6 -2.51963292 1.1015291
9 
.194 -5.8504322 .8111664 
9 -1.28283526 .99524033 .701 -4.2922388 1.7265682 
12 .41382923 1.1775842
4 
.996 -3.1469450 3.9746035 
6 1 -.89538575 .93096208 .869 -3.7104250 1.9196535 
3 2.51963292 1.1015291
9 
.194 -.8111664 5.8504322 
9 1.23679766 .90397192 .654 -1.4966288 3.9702241 
12 2.93346215 1.1015291
9 
.100 -.3973372 6.2642615 
9 1 -2.13218341 .80238841 .101 -4.5584421 .2940753 
3 1.28283526 .99524033 .701 -1.7265682 4.2922388 
6 -1.23679766 .90397192 .654 -3.9702241 1.4966288 
12 1.69666449 .99524033 .456 -1.3127390 4.7060680 








12 1 -3.82884790* 1.0198178
6 
.011 -6.9125689 -.7451269 
3 -.41382923 1.1775842
4 
.996 -3.9746035 3.1469450 
6 -2.93346215 1.1015291
9 
.100 -6.2642615 .3973372 
9 -1.69666449 .99524033 .456 -4.7060680 1.3127390 
*. The mean difference is significant at the 0.05 level. 
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Proximal Near Side 
Table 8. Descriptive statistics of proximal near side bone   
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Table 9. Analysis of Variance (ANOVA) output for proximal near side  
 Sum of Squares df Mean Square F Sig. 
PhosphateAmideI Between Groups 87.262 4 21.816 2.444 .084 
Within Groups 160.658 18 8.925   
Total 247.920 22    
CarbonatePhosphate Between Groups .005 4 .001 .555 .698 
Within Groups .041 18 .002   
Total .046 22    
CarbonateAmideI Between Groups 9.281 4 2.320 6.148 .003 
Within Groups 6.793 18 .377   
Total 16.074 22    
FWHMPhosphate Between Groups 63.803 4 15.951 10.622 .000 
Within Groups 27.029 18 1.502   






Table 10.  Multiple comparisons test using Tukey HSD for proximal near side 








J) Std. Error Sig. 





PhosphateAmideI 1 3 -.62390051 2.1125129
4 
.998 -7.0117082 5.7639072 
6 .84848238 1.9284516
5 
.992 -4.9827616 6.6797264 
9 3.53093546 1.6621162
9 
.253 -1.4949648 8.5568357 
12 4.72372554 2.1125129
4 
.211 -1.6640822 11.1115333 
3 1 .62390051 2.1125129
4 
.998 -5.7639072 7.0117082 
6 1.47238289 2.2817747
7 
.965 -5.4272380 8.3720038 
9 4.15483597 2.0616015
3 
.298 -2.0790261 10.3886980 
12 5.34762605 2.4393198
3 
.227 -2.0283790 12.7236311 
6 1 -.84848238 1.9284516
5 
.992 -6.6797264 4.9827616 
3 -1.47238289 2.2817747
7 
.965 -8.3720038 5.4272380 
9 2.68245308 1.8725425
8 
.616 -2.9797333 8.3446394 
12 3.87524316 2.2817747
7 
.459 -3.0243778 10.7748641 
9 1 -3.53093546 1.6621162
9 
.253 -8.5568357 1.4949648 
3 -4.15483597 2.0616015
3 
.298 -10.3886980 2.0790261 
6 -2.68245308 1.8725425
8 
.616 -8.3446394 2.9797333 
12 1.19279008 2.0616015
3 
.977 -5.0410719 7.4266521 
12 1 -4.72372554 2.1125129
4 





.227 -12.7236311 2.0283790 
6 -3.87524316 2.2817747
7 
.459 -10.7748641 3.0243778 
9 -1.19279008 2.0616015
3 
.977 -7.4266521 5.0410719 
CarbonatePhosphat
e 
1 3 .03686138 .03354879 .805 -.0645833 .1383061 
6 .03196102 .03062571 .832 -.0606449 .1245669 
9 .01343467 .02639604 .985 -.0663816 .0932509 
12 .03710263 .03354879 .801 -.0643421 .1385473 
3 1 -.03686138 .03354879 .805 -.1383061 .0645833 
6 -.00490036 .03623683 1.000 -.1144731 .1046724 
9 -.02342671 .03274026 .950 -.1224266 .0755732 
12 .00024125 .03873880 1.000 -.1168970 .1173795 
6 1 -.03196102 .03062571 .832 -.1245669 .0606449 
3 .00490036 .03623683 1.000 -.1046724 .1144731 
9 -.01852635 .02973782 .969 -.1084474 .0713947 
12 .00514161 .03623683 1.000 -.1044312 .1147144 
9 1 -.01343467 .02639604 .985 -.0932509 .0663816 
3 .02342671 .03274026 .950 -.0755732 .1224266 
6 .01852635 .02973782 .969 -.0713947 .1084474 
12 .02366796 .03274026 .948 -.0753319 .1226678 
12 1 -.03710263 .03354879 .801 -.1385473 .0643421 
3 -.00024125 .03873880 1.000 -.1173795 .1168970 
6 -.00514161 .03623683 1.000 -.1147144 .1044312 
9 -.02366796 .03274026 .948 -.1226678 .0753319 
CarbonateAmideI 1 3 .40693511 .43439183 .879 -.9065771 1.7204473 
6 .85455590 .39654367 .241 -.3445112 2.0536230 
9 1.46639543* .34177766 .004 .4329296 2.4998613 
12 1.60239211* .43439183 .013 .2888799 2.9159043 
3 1 -.40693511 .43439183 .879 -1.7204473 .9065771 
6 .44762079 .46919680 .872 -.9711345 1.8663761 
9 1.05946031 .42392301 .135 -.2223963 2.3413169 
12 1.19545700 .50159248 .165 -.3212562 2.7121702 
6 1 -.85455590 .39654367 .241 -2.0536230 .3445112 
3 -.44762079 .46919680 .872 -1.8663761 .9711345 





9 .61183953 .38504720 .522 -.5524646 1.7761436 
12 .74783621 .46919680 .520 -.6709191 2.1665915 
9 1 -1.46639543* .34177766 .004 -2.4998613 -.4329296 
3 -1.05946031 .42392301 .135 -2.3413169 .2223963 
6 -.61183953 .38504720 .522 -1.7761436 .5524646 
12 .13599669 .42392301 .997 -1.1458599 1.4178533 
12 1 -1.60239211* .43439183 .013 -2.9159043 -.2888799 
3 -1.19545700 .50159248 .165 -2.7121702 .3212562 
6 -.74783621 .46919680 .520 -2.1665915 .6709191 
9 -.13599669 .42392301 .997 -1.4178533 1.1458599 
FWHMPhosphate 1 3 -3.70284350* .86648942 .004 -6.3229306 -1.0827564 
6 -.78134998 .79099301 .857 -3.1731513 1.6104513 
9 .22569019 .68175023 .997 -1.8357833 2.2871637 
12 2.63627634* .86648942 .048 .0161893 5.2563634 
3 1 3.70284350* .86648942 .004 1.0827564 6.3229306 
6 2.92149352* .93591555 .041 .0914760 5.7515110 
9 3.92853369* .84560709 .002 1.3715905 6.4854769 
12 6.33911984* 1.0005358
1 
.000 3.3137039 9.3645358 
6 1 .78134998 .79099301 .857 -1.6104513 3.1731513 
3 -2.92149352* .93591555 .041 -5.7515110 -.0914760 
9 1.00704016 .76806078 .688 -1.3154188 3.3294991 
12 3.41762632* .93591555 .014 .5876088 6.2476438 
9 1 -.22569019 .68175023 .997 -2.2871637 1.8357833 
3 -3.92853369* .84560709 .002 -6.4854769 -1.3715905 
6 -1.00704016 .76806078 .688 -3.3294991 1.3154188 
12 2.41058615 .84560709 .070 -.1463570 4.9675293 
12 1 -2.63627634* .86648942 .048 -5.2563634 -.0161893 
3 -6.33911984* 1.0005358
1 
.000 -9.3645358 -3.3137039 
6 -3.41762632* .93591555 .014 -6.2476438 -.5876088 
9 -2.41058615 .84560709 .070 -4.9675293 .1463570 
*. The mean difference is significant at the 0.05 level. 
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Table 11. Descriptive statistics of proximal far side bone  
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Table 12. Analysis of variance (ANOVA) output for proximal far side  
 
Sum of 
Squares df Mean Square F Sig. 
PhosphateAmideI Between Groups 143.040 4 35.760 1.068 .404 
Within Groups 535.545 16 33.472   
Total 678.585 20    
CarbonatePhosphate Between Groups .022 4 .005 .732 .583 
Within Groups .118 16 .007   
Total .140 20    
CarbonateAmideI Between Groups 11.591 4 2.898 2.891 .056 
Within Groups 16.037 16 1.002   
Total 27.628 20    
FWHMPhosphate Between Groups 25.833 4 6.458 3.127 .044 
Within Groups 33.045 16 2.065   







Table 13.  Multiple comparisons test using Tukey HSD for proximal far side 
Tukey HSD   
Dependent Variable (I) Month (J) Month 
Mean 
Difference (I-
J) Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
PhosphateAmideI 1 3 .16666249 4.84046259 1.000 -14.6629318 14.9962568 
6 4.16383550 3.88100413 .818 -7.7262919 16.0539629 
9 5.81024639 3.38761813 .453 -4.5683077 16.1888004 
12 .27647348 4.22510213 1.000 -12.6678577 13.2208046 
3 1 -.16666249 4.84046259 1.000 -14.9962568 14.6629318 
6 3.99717301 5.01035478 .927 -11.3529154 19.3472615 
9 5.64358391 4.63868716 .742 -8.5678365 19.8550043 
12 .10981100 5.28137767 1.000 -16.0706029 16.2902249 
6 1 -4.16383550 3.88100413 .818 -16.0539629 7.7262919 
3 -3.99717301 5.01035478 .927 -19.3472615 11.3529154 
9 1.64641090 3.62622856 .990 -9.4631675 12.7559893 
12 -3.88736202 4.41871758 .900 -17.4248676 9.6501435 
9 1 -5.81024639 3.38761813 .453 -16.1888004 4.5683077 
3 -5.64358391 4.63868716 .742 -19.8550043 8.5678365 
6 -1.64641090 3.62622856 .990 -12.7559893 9.4631675 
12 -5.53377291 3.99234625 .645 -17.7650162 6.6974703 
12 1 -.27647348 4.22510213 1.000 -13.2208046 12.6678577 
3 -.10981100 5.28137767 1.000 -16.2902249 16.0706029 
6 3.88736202 4.41871758 .900 -9.6501435 17.4248676 
9 5.53377291 3.99234625 .645 -6.6974703 17.7650162 
CarbonatePhosphate 1 3 .05903575 .07187529 .920 -.1611666 .2792381 
6 .00865848 .05762844 1.000 -.1678962 .1852132 
9 -.01378057 .05030222 .999 -.1678901 .1403290 
12 .07476416 .06273789 .756 -.1174442 .2669725 
3 1 -.05903575 .07187529 .920 -.2792381 .1611666 
6 -.05037728 .07439799 .959 -.2783084 .1775538 
9 -.07281632 .06887916 .825 -.2838395 .1382069 
12 .01572840 .07842237 1.000 -.2245321 .2559889 
6 1 -.00865848 .05762844 1.000 -.1852132 .1678962 
3 .05037728 .07439799 .959 -.1775538 .2783084 
9 -.02243905 .05384531 .993 -.1874035 .1425254 
12 .06610568 .06561286 .848 -.1349107 .2671220 
9 1 .01378057 .05030222 .999 -.1403290 .1678901 
110 
 
3 .07281632 .06887916 .825 -.1382069 .2838395 
6 .02243905 .05384531 .993 -.1425254 .1874035 
12 .08854473 .05928174 .581 -.0930751 .2701646 
12 1 -.07476416 .06273789 .756 -.2669725 .1174442 
3 -.01572840 .07842237 1.000 -.2559889 .2245321 
6 -.06610568 .06561286 .848 -.2671220 .1349107 
9 -.08854473 .05928174 .581 -.2701646 .0930751 
CarbonateAmideI 1 3 1.03714955 .83763705 .730 -1.5290964 3.6033955 
6 1.50880078 .67160375 .213 -.5487735 3.5663750 
9 1.93728484* .58622382 .031 .1412868 3.7332829 
12 1.44654240 .73114956 .319 -.7934607 3.6865455 
3 1 -1.03714955 .83763705 .730 -3.6033955 1.5290964 
6 .47165123 .86703672 .981 -2.1846657 3.1279682 
9 .90013528 .80272002 .793 -1.5591363 3.3594069 
12 .40939285 .91393695 .991 -2.3906111 3.2093968 
6 1 -1.50880078 .67160375 .213 -3.5663750 .5487735 
3 -.47165123 .86703672 .981 -3.1279682 2.1846657 
9 .42848406 .62751511 .957 -1.4940170 2.3509851 
12 -.06225838 .76465451 1.000 -2.4049097 2.2803930 
9 1 -1.93728484* .58622382 .031 -3.7332829 -.1412868 
3 -.90013528 .80272002 .793 -3.3594069 1.5591363 
6 -.42848406 .62751511 .957 -2.3509851 1.4940170 
12 -.49074243 .69087139 .951 -2.6073464 1.6258616 
12 1 -1.44654240 .73114956 .319 -3.6865455 .7934607 
3 -.40939285 .91393695 .991 -3.2093968 2.3906111 
6 .06225838 .76465451 1.000 -2.2803930 2.4049097 
9 .49074244 .69087139 .951 -1.6258616 2.6073464 
FWHMPhosphate 1 3 -2.98653660 1.20237746 .144 -6.6702279 .6971547 
6 -.72192860 .96404668 .941 -3.6754523 2.2315951 
9 .16532973 .84148893 1.000 -2.4127172 2.7433766 
12 1.44443230 1.04952109 .650 -1.7709571 4.6598217 
3 1 2.98653660 1.20237746 .144 -.6971547 6.6702279 
6 2.26460800 1.24457892 .397 -1.5483748 6.0775908 
9 3.15186633 1.15225618 .092 -.3782698 6.6820024 
12 4.43096890* 1.31190137 .027 .4117322 8.4502056 
6 1 .72192860 .96404668 .941 -2.2315951 3.6754523 

















3 -2.26460800 1.24457892 .397 -6.0775908 1.5483748 
9 .88725833 .90076009 .858 -1.8723760 3.6468927 
12 2.16636090 1.09761543 .321 -1.1963738 5.5290956 
9 1 -.16532973 .84148893 1.000 -2.7433766 2.4127172 
3 -3.15186633 1.15225618 .092 -6.6820024 .3782698 
6 -.88725833 .90076009 .858 -3.6468927 1.8723760 
12 1.27910256 .99170422 .701 -1.7591548 4.3173600 
12 1 -1.44443230 1.04952109 .650 -4.6598217 1.7709571 
3 -4.43096890* 1.31190137 .027 -8.4502056 -.4117322 
6 -2.16636090 1.09761543 .321 -5.5290956 1.1963738 
9 -1.27910256 .99170422 .701 -4.3173600 1.7591548 
*. The mean difference is significant at the 0.05 level. 
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